Karyopharm Therapeutics, Inc. (KPTI)
0.3464
-0.04
(-11.20%)
USD |
NASDAQ |
Oct 19, 15:33
Karyopharm Therapeutics Cash from Operations (Annual) : -75.37M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -75.37M |
| December 31, 2024 | -127.49M |
| December 31, 2023 | -92.72M |
| December 31, 2022 | -149.55M |
| December 31, 2021 | -107.12M |
| December 31, 2020 | -160.23M |
| December 31, 2019 | -190.82M |
| December 31, 2018 | -159.12M |
| Date | Value |
|---|---|
| December 31, 2017 | -73.72M |
| December 31, 2016 | -84.39M |
| December 31, 2015 | -94.03M |
| December 31, 2014 | -51.45M |
| December 31, 2013 | -30.29M |
| December 31, 2012 | -15.51M |
| December 31, 2011 | -8.549M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -189.55M |
| Relay Therapeutics, Inc. | -235.46M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |